Untangling the Clinical and Methodological Assessment of Risks Associated With BK Nephropathy
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Binet I, Nickeleit V, Hirsch H, Prince O, Dalquen P, Gudat F
. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation. 1999; 67(6):918-22.
DOI: 10.1097/00007890-199903270-00022.
View
2.
Schold J, Rehman S, Kayle L, Kayler L, Magliocca J, Srinivas T
. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int. 2009; 22(6):626-34.
DOI: 10.1111/j.1432-2277.2009.00842.x.
View
3.
Dharnidharka V, Cherikh W, Abbott K
. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation. 2009; 87(7):1019-26.
DOI: 10.1097/TP.0b013e31819cc383.
View
4.
Gately R, Milanzi E, Lim W, Teixeira-Pinto A, Clayton P, Isbel N
. Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients With BK Polyomavirus-Associated Nephropathy. Kidney Int Rep. 2023; 8(3):531-543.
PMC: 10014440.
DOI: 10.1016/j.ekir.2022.12.020.
View